Case Report

Intravitreal Bevacizumab Injection Therapy in a Case with Choroidal Neovascular Membrane Secondary to Toxoplasmosis Retinochoroiditis

10.4274/tjo.29494

  • Sirel Gür Güngör
  • Imren Akkoyun
  • Evin Singar
  • Gürsel Yilmaz

Received Date: 21.03.2013 Accepted Date: 09.09.2013 Turk J Ophthalmol 2014;44(3):237-239

A 57-year-old male patient presenting with visual loss in the left eye was diagnosed as choroidal neovascular membrane secondary to inactive toxoplasmosis retinochoroiditis scar. He underwent intravitreal bevacizumab injection as primary therapy. The choroidal neovascular membrane regressed partially and the initial visual acuity improved from 1/10 to 3/10. Intravitreal bevacizumab injection appears to be effective in the treatment of choroidal neovascular membrane secondary to toxoplasma retinochoroiditis.

Keywords: Choroidal neovascular membrane, toxoplasmosis retinochoroiditis, bevacizumab

Full Text (Turkish)